Equities

Enzon Pharmaceuticals Inc

Enzon Pharmaceuticals Inc

Actions
  • Price (USD)0.0949
  • Today's Change0.006 / 7.11%
  • Shares traded20.25k
  • 1 Year change-40.78%
  • Beta0.3687
Data delayed at least 15 minutes, as of May 17 2024 20:37 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • ENZN:QXR price moved over +7.11% to 0.0949

Key statistics

On Friday, Enzon Pharmaceuticals Inc (ENZN:QXR) closed at 0.0949, 58.17% above the 52 week low of 0.06 set on Apr 01, 2024.
52-week range
Today
0.06Apr 01 20240.2194Jun 16 2023
Open0.0949
High0.0949
Low0.0886
Bid--
Offer--
Previous close0.0886
Average volume20.46k
Shares outstanding74.21m
Free float66.17m
P/E (TTM)64.34
Market cap6.30m USD
EPS (TTM)0.0013
USD
Data delayed at least 15 minutes, as of May 17 2024 20:37 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.